by: Parent Project Muscular DystrophyItalfarmaco Provides Givinostat Update (March 2019)
Italfarmaco joined PPMD for a webinar on March 27, 2019 to update the community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy.
